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ABSTRACT
Objective: Irritable bowel syndrome (IBS), a subgroup of functional somatic disorders, may be associated with autonomic dysfunction (AD). 
Heart rate variability (HRV), a measure of autonomic dysfunction, may predict survival. The aim of this study was to investigate the effect of IBS 
on HRV parameters, carotid intima-media thickness (CIMT) and carotid-femoral pulse wave velocity (cf-PWV) as surrogates of AD, subclinical 
atherosclerosis and arterial stiffness, respectively.
Methods: Our study was cross-sectional and observational. Thirty consecutive patients with IBS and 30 control participants underwent 24-hour 
Holter monitoring, cf-PWV assessment and CIMT measurement. The diagnosis of IBS was based on Rome III criteria. There were 24 patients 
with IBS-Constipation (80%), 4 patients with IBS-Diarrhea (13.3%), and 2 patients with IBS-Mixed (6.7%) in IBS group. Student t-test and χ2 test 
were utilized in order to compare continuous and categorical variables between two groups, respectively.
Results: Biochemical parameters did not differ between groups except for slightly increased creatinine in patients with IBS. cf-PWV and CIMT 
values were similar between groups. SDNN index and RMSSD were significantly impaired in patients with IBS compared to controls. Frequency 
analyses revealed lower LF, HF, and VLF in subjects with IBS. 
Conclusion: We demonstrated decreased parasympathetic modulation in patients with constipation predominant IBS. However, we could not 
demonstrate any changes in vascular structure and functions measured by carotid intima-media thickness and pulse wave velocity. Our results 
do not support accelerated atherosclerosis in IBS population (Anadolu Kardiyol Derg 2014; 14: 525-30).
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Introduction
Irritable bowel syndrome (IBS) is a functional disorder char-
acterized with recurrent abdominal pain or discomfort which is 
associated with alterations in frequency or form of stool and 
improvement after defecation (1). IBS is highly prevalent, affect-
ing nearly 20% of general population. Although the pathophysi-
ology of this syndrome have not been clarified; impaired auto-
nomic regulation, altered intestinal motility and increased vis-
ceral sensitivity have been proposed as mediators (2). 
Arterial stiffness (AS) due to decreased arterial compliance 
is one of the major signs of vascular aging (3). Several studies 
have documented the prognostic importance of arterial stiffness 
as an independent predictor of all-cause mortality and cardio-
vascular mortality (4, 5). Carotid-femoral pulse wave velocity 
(cf-PWV) has been accepted as the gold standard measurement 
of arterial stiffness. Carotid-femoral pulse wave velocity is a 
well-recognized predictor of an adverse cardiovascular out-
come with higher predictive value than classical cardiovascular 
risk factors and requires little technical expertise (6).
Non-invasive measurement of carotid intima-media thick-
ness (CIMT) using B-Mode ultrasonography is a valid surrogate 
marker of atherosclerotic disease (7). An increase in CIMT is 
associated with increased cardiovascular risk factors (8) and 
cardiovascular events (9). CIMT is a reliable, reproducible and 
quantifiable method for detecting subclinical cardiovascular 
disease, which is independent of traditional risk factors (10).
Heart rate variability (HRV) is a validated tool in estimating 
autonomic functions (11). An abnormal HRV predicts mortality in 
patients after myocardial infarction (12) and is associated with 
coronary artery disease in patients with diabetes mellitus (13). 
The association of altered HRV and IBS has long been sought. 
Although, several observational studies has focused on impaired 
HRV in patients with IBS, the results of these studies are contro-
versial; some found no difference (14-16) whereas others 
revealed differences in HRV when patient characteristics like 
predominant bowel patterns (14, 17), pain severity (18), sleep 
patterns (16), and presence of anxiety or depression (19) were 
taken into account. To date, the association of HRV and athero-
sclerosis markers in the setting of IBS has not been evaluated. 
Since long standing autonomic dysregulation may increase 
atherosclerosis in certain populations, we planned to investi-
gate whether HRV parameters, CIMT and cf-PWV as surrogates 
of autonomic dysfunction, subclinical atherosclerosis, and arte-




Our study was cross-sectional and observational, consisting 
of 30 female patients with IBS (mean age: 45±12 yrs) and 30 
healthy control women (mean age: 47±10 yrs). Informed consent 
was obtained from all patients prior to the study. The study was 
performed in accordance with the principles stated in the 
Declaration of Helsinki and was approved by the Local Ethics 
Committee.
Patient selection 
Women in the IBS group were diagnosed if they were expe-
riencing symptoms compatible with Rome III criteria (1). 
Predominant bowel patterns were defined using Bristol stool 
scale (20) and Rome III criteria (1). Patients with a predominant 
(>25% of time) Bristol stool scale 1-2 pattern were classified as 
IBS-Constipation (IBS-C), patients with a predominant 6-7 pat-
tern were acknowledged as IBS-Diarrhea (IBS-D), and the 
remaining patients were assigned to mixed (IBS-M) group.
Patients with previous cardiovascular disease, inflammatory 
bowel disease, previous gastrointestinal surgery, chronic renal 
and liver failure, history of cardiac arrhythmia, and patients tak-
ing medications that could interfere with HRV such as beta-
blockers, antihistaminic agents, benzodiazepines, or antidepres-
sants were excluded.
Control subjects were recruited among healthy volunteers 
without a history of cardiovascular disease and symptoms com-
patible with IBS, who were seen by their family physician for 
routine annual examination and agreed to join a vascular health-
screening study for research purposes.
Baseline characteristics
Baseline characteristics were recorded during interview 
with the patient. Hypertension was defined as active use of 
antihypertensive drugs or documentation of blood pressure 
more than 140/90 mm Hg (21). Diabetes mellitus was defined as 
fasting plasma glucose levels over 126 mg/dL or glucose level 
over 200 mg/dL at any measurement or active use of antidia-
betic treatment (22). Patients who were using tobacco products 
on admission to our hospital and those quitted smoking within 
the last year were considered as smokers. Body mass index 
(BMI) was calculated by the following formula: BMI=weight 
(kg)/height2 (m).
Measurement of heart rate variability
All participants underwent a 24-hour Holter recording to 
assess heart rate variability parameters. Holter evaluations 
were performed by an experienced physician who was blind to 
the study population. Holter ECG was performed using a 3-chan-
nel digitized recorder (DMS 300-3A, DM Software, Nevada, 
USA). Data was manually preprocessed before analysis. 
Recordings lasting for at least 18 h and of sufficient quality for 
evaluation were included in the analysis. If these criteria were 
not achieved, the recordings were repeated. 
The time domain HR variability indices: SDNN [the standard 
deviation of all NN (normal to normal) intervals], SDNN index 
(the mean of the deviation of 5 min NN intervals over the entire 
recording), SDANN (standard deviation of the average NN inter-
vals calculated over 5 min periods of the entire recording), and 
RMSSD (the square root of the mean squared differences of 
successive NN intervals) were measured. 
The frequency domain analysis of HR variability included 
total power, high frequency (HF) component (0.15-0.40 Hz), low 
frequency (LF) component (0.04-0.15 Hz), and very low frequency 
(VLF) component (0.003-0.04 Hz). The normalized HF and LF were 
calculated using the following formula: HFnu=HF/(total power-
VLF) and LFnu=LF/(Total power-VLF), respectively (11). 
Assessment of pulse wave velocity
Carotid-femoral pulse wave velocity was measured as an 
index of arterial stiffness. Vascular assessments in both patients 
and controls were performed by a single experienced cardiolo-
gist who was blinded to patient data, in the morning after an 
overnight fast and refraining from cigarette smoking for the prior 
8 hours. PWV was calculated from the measurements of pulse 
transmission time and the distance between the 2 recording 
sites by a validated non-invasive device (SphygmoCor, AtCor 
Medical, Sydney, Australia). Carotid and femoral pulses were 
palpated to confirm measurement localization in the corre-
sponding regions. Straight distances from the strongest point of 
pulses in the carotid and femoral area to the sternal notch were 
measured. The distance traveled by the pulse wave over the 
surface of the body was measured with a tape measure (from 
the sternal notch to right femoral artery minus the distance from 
the sternal notch to the right carotid artery) and was divided by 
the transit time; the result was expressed as meters/second 
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(m/sec). Resting blood pressure was detected by auscultation 
using a sphygmomanometer.
Measurement of carotid intima-media thickness
Ultrasonography was performed on all patients using a high-
resolution ultrasonography scanner (Xario, Toshiba Medical 
Systems, Tokyo, Japan) with a PLT-805AT linear array transducer. 
Measurements were performed on the right and left carotid 
arteries. The patient was lying supine with the head directed 
away from the side of interest and the neck slightly extended. 
The transducer was manipulated so that the near and far walls 
of the CCA were parallel, and the lumen diameter was maxi-
mized in the longitudinal plane. The region 1 cm proximal to the 
carotid bifurcation was identified, and the CIMT of the far wall 
was evaluated as the distance between the lumen-intima inter-
face and the media-adventitia interface. The CIMT was mea-
sured on the frozen frame of a suitable longitudinal image, with 
the image magnified to achieve a higher resolution of detail. The 
CIMT measurement was obtained from 4 contiguous sites at 
1-mm intervals on each carotid artery, and the average of all 8 
measurements was used for analysis. All measurements were 
performed by the same radiologist who was blinded to patient 
data. The intra-observer mean absolute difference in measuring 
the common carotid intima-media thickness was 0.026±0.043 
mm (coefficient of variation: 1.6%, intra-class correlation: 0.95).
Biochemical measurements
Blood samples were drawn by venipuncture to evaluate 
routine blood parameters after fasting for at least 8 hours. 
Fasting blood glucose, total cholesterol, high-density lipoprotein 
(HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and 
triglyceride levels were recorded. Glucose and lipid profile were 
determined by standard methods. Serum CRP was analyzed 
using a nephelometric technique (Beckman Coulter Immage 800; 
Fullerton, CA, USA; normal range 0-0.8 mg/dL).
Statistical analysis
Continuous variables were given as mean±SD; categorical 
variables were defined as percentages. Data were tested for 
normal distribution using the Kolmogorov-Smirnov test. 
Continuous variables were compared by Student t-test and the 
χ2 test was used for the categorical variables between two 
groups. All tests of significance were two-tailed. Statistical sig-
nificance was defined as p<0.05. The SPSS statistical software 
(IBM SPSS Statistics for Windows, Version 20.0, IBM Corp., 
Armonk, NY, USA) was used for all statistical calculations.
Results
Clinical characteristics
The characteristics of the patients are presented in Table 1. 
Clinical parameters were similar between groups. There were 
24 patients with IBS-C (80%), 4 patients with IBS-D (13.3%), and 
2 patients with IBS-M (6.7%) in IBS group.
Biochemical measurements
Biochemical parameters did not differ between groups 
except for slightly increased creatinine (0.72±0.10 vs. 0.65±0.11 
mg/dL, p=0.045), and HDL-cholesterol concentrations (53±10 vs. 
50±7 mg/dL, p=0.023) in patients with IBS. 
PWV, CIMT and HRV parameters
PWV and CIMT values were similar between groups (Table 
2). We found significantly lower SDNN index (51±12 ms vs. 62±18 
ms, p=0.010), and RMSSD (28±9ms vs. 38±15 ms, p=0.002) in 
patients with IBS compared to controls.
Frequency analyses revealed lower LF (585±302 vs. 919±436, 
p=0.002), HF (228±177 vs. 405±275, p=0.006), and VLF (1871±803 
vs. 2646±1461, p=0.016) in subjects with IBS. However LF/HF 
ratio, LFnu, and HFnu were not significantly different between 
two groups.
Discussion
In this study, we demonstrated impaired HRV as surrogate of 
autonomic dysfunction in patients with IBS. However, we could 
 IBS Control
Parameters group(30)  group (30) P*
Age, years 45±12 47±10 NS
BMI, kg/m2 29.4±5.9 29.7±5.9 NS
Hypertension, % 23% 37% NS
Diabetes mellitus, % 3% 13% NS
Smoking, n, % 10% 3% NS
Biochemistry and hematology
Glucose, mg/dL 100±17 102±17 NS
Creatinine, mg/dL 0.72±0.10 0.65±0.11 0.045
Total cholesterol, mg/dL 206±45 206±48 NS
Triglycerides, mg/dL 136±108 133±87 NS
HDL cholesterol, mg/dL 53±10 50±7 0.023
LDL cholesterol, mg/dL 123±32 131±39 NS
Hemoglobin, mg/dL 12.8±1.0 13.0±1.3 NS
Leukocytes, 103/mm3 7.09±2.22 7.40±1.78 NS
Platelets, 103/mm3 288±58 292±67 NS
CRP, mg/dL 0.45±0.23 0.44±0.37 NS
Continuous variables were given as mean±standard deviation; categorical variables 
were defined as percentages. BMI - body mass index; CRP - C-reactive protein; HDL - 
high-density lipoprotein; IBS - irritable bowel syndrome; LDL - low-density lipoprotein, 
NS - not significant.
*Continuous variables were compared by Student t test and the χ2 test was used for 
the categorical variables between two groups.
Table 1. Demographic and clinical characteristics of study participants 
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not document any difference in PWV and CIMT as surrogates of 
arterial stiffness and atherosclerosis. 
Arterial stiffness, one of the earliest manifestations of adverse 
structural and functional changes within the arterial wall, is mainly 
associated with aging and hypertension (23). Pulse wave velocity, 
the gold-standard measure of arterial stiffness, has been shown to 
be an independent predictor of mortality and stroke in the general 
population (4) and in patients with end-stage renal disease (24), 
hypertension (25), or diabetes (26). PWV is significantly associated 
with the markers of subclinical target organ damage in the coro-
nary, peripheral arterial, and cerebral vascular beds (27). Carotid 
intima-media thickness, the surrogate of cardiovascular disease, is 
associated with conventional cardiovascular risk factors and ath-
erosclerosis (8). Moreover, CIMT relates to several CVD risk scores 
in the elderly, predicts cardiovascular events, and gives informa-
tion beyond conventional risk factors (9, 28, 29). 
Several studies investigated HRV patterns in patients with 
IBS compared to healthy controls and failed to demonstrate any 
difference (14-16). However, current evidence support altered 
HRV and autonomic functions when predominant bowel pat-
terns (14, 17), pain severity (18), sleep patterns (16), and pres-
ence of anxiety or depression (19) are taken into account. A 
recent meta-analysis comparing 392 IBS patients with 263 
healthy control subjects revealed lower HF band and higher LF/
HF ratio in patients with IBS. Interestingly they demonstrated 
decreased HF power in patients with IBS-C while no difference 
was observed in LF/HF ratio which is in line with our study (30).
We revealed decreased RMSSD, LF and HF in patients with 
IBS, all of which is in line with decreased parasympathetic modu-
lation of autonomic nervous system (11). Since IBS group mainly 
had patients with IBS-C subgroup; this result is similar to previous 
studies that reported reduced parasympathetic tone in constipa-
tion predominant bowel pattern (14, 17). However, we did not 
demonstrate any differences in HFnu, LFnu and LF/HF ratio 
between two groups. Since HF mainly reflects parasympathetic 
modulation and LF reflects both sympathetic and parasympathetic 
influence; LF/HF is a measure of autonomic nervous system rather 
than sympathovagal imbalance. Moreover, HFnu, LFnu and LF/HF 
ratio are mathematically close to each other and these parameters 
per se do not reflect distinct autonomic phenomenon (31). 
Decreased heart rate variability may predict atherosclerotic 
progression of carotid arteries in patients with type 1 diabetes 
population (32). Similarly, decreased HRV is associated with 
coronary artery disease, myocardial infarction and cardiovas-
cular mortality in diabetic patients (13). However, this associa-
tion has not been proven in non-diabetics and currently not 
known in asymptomatic population. 
Even though, autonomic dysfunction and altered HRV is 
related to accelerated atherosclerosis in certain populations, 
like patients with diabetes mellitus; we failed to demonstrate 
any changes in pulse wave velocity and carotid intima-media 
thickness in this population. Since atherosclerosis is a multifac-
torial disorder, the influence of autonomic dysfunction solely 
may not be adequate for accelerated atherosclerosis without 
strong precipitating factors.
Study limitations
Our study has several limitations; the most important is the 
small sample size. IBS group mainly had IBS-C patients; there-
fore, our results only apply to this subgroup. Since patients were 
recruited from gastroenterology clinic, they may have high 
degree of pain and severe disease. Moreover, our study is cross-
sectional in nature; therefore, our results cannot implicate cau-
sality. However, in order to decrease variability in measuring 
atherosclerotic parameters, we utilized validated end-points, 
which are the stronger aspects of our study.
Conclusion
We demonstrated decreased parasympathetic modulation in 
patients with constipation predominant IBS. However, we could 
 IBS Control P
N (60) group (30) group (30)  value*
HRV measurements
Time domain HR 
SDNN, ms 136±35 151±39 NS
SDANN, ms 120±27 137±39 0.060
SDNN index, ms 51±12 62±18 0.010
RMSSD, ms 28±9 38±15 0.002
Total power 2718±1201 4004±2112 0.007
Frequency domain HR
LF 585±302 919±436 0.002
LFnu  0.70±0.12 0.70±0.09 NS
HF 228±177 405±275 0.006
Hfnu  0.26±0.07 0.28±0.08 NS
VLF 1871±803 2646±1461 0.016
LF/HF ratio 3.1±1.6 2.8±1.5 NS
Vascular tests
CIMT, mean, mm 0.64±0.16 0.70±0.23 NS
cf-PWV, m/s 7.42±2.11 7.8±1.95 NS
cf-PWV - carotid-femoral pulse wave velocity; CIMT - carotid intima-media thickness; 
HF - high frequency power; IBS - irritable bowel syndrome; HFnu - normalized high 
frequency power; HRV - heart rate variability; LF - low frequency power; LFnu - 
normalized low frequency power; NS - not significant; RMSDD - square root of the mean 
squared differences of successive normal-to-normal intervals; SDNN - standard 
deviation of all normal-to-normal intervals; SDANN - standard deviation of the average 
normal-to-normal intervals calculated over 5-minute periods of the entire recording
Continuous variables were given as mean±standard deviation; categorical variables 
were defined as percentages. *Continuous variables were compared by Student t-test 
and the χ2 test was used for the categorical variables between two groups.
Table 2. Heart rate variability and vascular tests in two groups
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not demonstrate any changes in pulse wave velocity and carotid 
intima-media thickness. Our results do not support accelerated 
atherosclerosis in IBS population.
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